These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 24766105)

  • 1. The effect of a calorie-restricted diet on weight gain in short-term psychiatric inpatients receiving atypical antipsychotic medications.
    Jacobowitz W; Derbabian B; Saunders A
    J Psychosoc Nurs Ment Health Serv; 2014 Jul; 52(7):30-7. PubMed ID: 24766105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsychotic-induced body weight gain: predictors and a systematic categorization of the long-term weight course.
    Gebhardt S; Haberhausen M; Heinzel-Gutenbrunner M; Gebhardt N; Remschmidt H; Krieg JC; Hebebrand J; Theisen FM
    J Psychiatr Res; 2009 Mar; 43(6):620-6. PubMed ID: 19110264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weight gain with risperidone among patients with mental retardation: effect of calorie restriction.
    Cohen S; Glazewski R; Khan S; Khan A
    J Clin Psychiatry; 2001 Feb; 62(2):114-6. PubMed ID: 11247096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newer antipsychotic drugs and obesity in children and adolescents. How should we assess drug-associated weight gain?
    Vieweg WV; Sood AB; Pandurangi A; Silverman JJ
    Acta Psychiatr Scand; 2005 Mar; 111(3):177-84. PubMed ID: 15701101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weight gain due to long term antipsychotic treatment of persistent mental disorders.
    Tadger S; Melamed Y
    Psychiatr Danub; 2008 Mar; 20(1):37-41. PubMed ID: 18376329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia.
    Ascher-Svanum H; Stensland M; Zhao Z; Kinon BJ
    BMC Psychiatry; 2005 Jan; 5():3. PubMed ID: 15649317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenomic associations with weight gain in olanzapine treatment of patients without schizophrenia.
    Houston JP; Kohler J; Bishop JR; Ellingrod VL; Ostbye KM; Zhao F; Conley RR; Poole Hoffmann V; Fijal BA
    J Clin Psychiatry; 2012 Aug; 73(8):1077-86. PubMed ID: 22967772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective comparison of BMI changes and the potential risk factors among schizophrenic inpatients treated with aripiprazole, olanzapine, quetiapine or risperidone.
    Lee SY; Park MH; Patkar AA; Pae CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):490-6. PubMed ID: 21146575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol.
    Saddichha S; Ameen S; Akhtar S
    J Clin Psychopharmacol; 2008 Feb; 28(1):27-31. PubMed ID: 18204337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The appearance of metabolic syndrome in treatment with atypical antipsychotics].
    Mosolov SN; Kabanov SO
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(11):62-9. PubMed ID: 14681970
    [No Abstract]   [Full Text] [Related]  

  • 11. Rates and predictors of adherence with atypical antipsychotic medication: a follow-up study of adolescent inpatients.
    Pogge DL; Singer MB; Harvey PD
    J Child Adolesc Psychopharmacol; 2005 Dec; 15(6):901-12. PubMed ID: 16379510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjunctive effects of aripiprazole on metabolic profiles: comparison of patients treated with olanzapine to patients treated with other atypical antipsychotic drugs.
    Wang LJ; Ree SC; Huang YS; Hsiao CC; Chen CK
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan; 40():260-6. PubMed ID: 23085073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weight gain in newly diagnosed first-episode psychosis patients and healthy comparisons: one-year analysis.
    Strassnig M; Miewald J; Keshavan M; Ganguli R
    Schizophr Res; 2007 Jul; 93(1-3):90-8. PubMed ID: 17478082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weight gain, obesity, and metabolic indices following a first manic episode: prospective 12-month data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM).
    Bond DJ; Kauer-Sant'Anna M; Lam RW; Yatham LN
    J Affect Disord; 2010 Jul; 124(1-2):108-17. PubMed ID: 19914720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel antipsychotics: comparison of weight gain liabilities.
    Wirshing DA; Wirshing WC; Kysar L; Berisford MA; Goldstein D; Pashdag J; Mintz J; Marder SR
    J Clin Psychiatry; 1999 Jun; 60(6):358-63. PubMed ID: 10401912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weight gain associated with olanzapine and risperidone in adolescent patients: a comparative prospective study.
    Ratzoni G; Gothelf D; Brand-Gothelf A; Reidman J; Kikinzon L; Gal G; Phillip M; Apter A; Weizman R
    J Am Acad Child Adolesc Psychiatry; 2002 Mar; 41(3):337-43. PubMed ID: 11886029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Observed clinical and health services outcomes in pediatric inpatients treated with atypical antipsychotics: 1999-2003.
    Flanders SC; Findling RL; Youngstrom EA; Pandina GJ; Rupnow MF; Jensik SE; Carlson GA
    J Child Adolesc Psychopharmacol; 2007 Jun; 17(3):312-27. PubMed ID: 17630865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiogenomic comparison of weight profiles of olanzapine- and risperidone-treated patients.
    Ruaño G; Goethe JW; Caley C; Woolley S; Holford TR; Kocherla M; Windemuth A; de Leon J
    Mol Psychiatry; 2007 May; 12(5):474-82. PubMed ID: 17199131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Latin America: clinical responses to the antipsychotic drugs].
    Assunção S; Jiménez J; Pacheco N; Navarro Marún F; Quintero D; Aspilcueta Flores I; Pérez Desanti CL; Rosado-Franco A; Tapia Paniagua G; Nieto Caraveo A; Sanchez Cázares S; Aguilar Gasca J; Landa Fournais E; Leadbetter J
    Vertex; 2005; 16(62):260-9. PubMed ID: 16077867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weight gain and new onset diabetes associated with olanzapine and risperidone.
    Farwell WR; Stump TE; Wang J; Tafesse E; L'Italien G; Tierney WM
    J Gen Intern Med; 2004 Dec; 19(12):1200-5. PubMed ID: 15610330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.